REBECCA GREEN: Open Payments
NPI 1982714416 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 17 payments from 7 companies in 2025. Trend: 2023 $174 · 2024 $534 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $143 |
| Corium, LLC | 4 | $59 |
| Tris Pharma Inc | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Bausch Health US, LLC | 1 | $21 |
| ABBVIE INC. | 1 | $16 |
Products named: LYBALVI, Azstarys, Dyanavel XR, CAPLYTA, TRINTELLIX, APLENZIN, VRAYLAR, ARISTADA.
Industry payments across AZ — which companies pay providers there.
